Stephanie Holinko
Registered dietitian
Nursing home medication error expert witness
Medication cases in long-term care come in three shapes. The first is a discrete error: wrong drug, wrong dose, wrong resident, wrong route, or a dose never given. The second is a systems failure: an order that was never transcribed, a hospital reconciliation that dropped an anticoagulant, a pharmacy consultant recommendation that was ignored for six months. The third is chemical restraint: psychotropic or antipsychotic medication used to manage staffing pressure rather than to treat a diagnosed condition.
The third category is where the regulations are most specific, and where the tag numbers recently moved. Unnecessary psychotropic drugs and the limits on PRN psychotropic orders were cited at F758 until 2025. Appendix PP now places those requirements at F605, alongside the right to be free from chemical restraints, so older survey reports and newer ones may cite different tags for the same conduct. F757 still addresses unnecessary drugs generally, including duplicate therapy, excessive duration, and use without adequate monitoring or indication. The record that proves or disproves the claim is the same either way: the MAR against the orders, the consultant pharmacist's monthly review, the behavior monitoring that was supposed to justify the drug, and the gradual dose reduction history.
Causation is a separate expert question. An omitted anticoagulant dose and a stroke three days later is an argument, not a conclusion, and it usually takes a physician to close the gap.
Records to request
- Medication administration records (MAR) for the full period at issue
- Physician orders, telephone orders, and order change history
- Consultant pharmacist monthly drug regimen reviews and the facility's responses
- Psychotropic consents, diagnoses supporting use, and gradual dose reduction attempts
- Behavior monitoring flow sheets used to justify PRN psychotropics
- Medication error reports and the facility's quality assurance follow-up
- Hospital discharge medication lists and the facility's reconciliation
- Laboratory results tied to the medication (INR, digoxin levels, glucose, sodium)
- Nurse notes and vital signs around the error
- Nursing competency and medication pass observation records
Federal requirements experts apply
Tags from the CMS State Operations Manual Appendix PP, Rev. 232 (July 23, 2025), with the 42 CFR Part 483 citation. Whether a regulation establishes the standard of care is a question for your venue.
| Tag | Requirement | Citation |
|---|---|---|
| F760 | Residents are free of significant medication errors | 42 CFR 483.45(f)(2) |
| F759 | Medication error rate of 5 percent or more | 42 CFR 483.45(f)(1) |
| F757 | Drug regimen free from unnecessary drugs | 42 CFR 483.45(d) |
| F605 | Free from chemical restraints, including unnecessary psychotropic drugs and PRN limits (formerly F758) | 42 CFR 483.10(e)(1), 483.12(a)(2), 483.45(c)(3), (e) |
| F756 | Drug regimen review, report irregularities, act on them | 42 CFR 483.45(c) |
| F755 | Pharmacy services, procedures, pharmacist, records | 42 CFR 483.45(a), (b) |
Appendix PP is revised periodically. Confirm the version in effect on the date of the incident.
What counsel should investigate
- Does the MAR match the orders, and are there initials for doses that could not have been given?
- How were PRN psychotropics justified, and were the PRN time limits now cited at F605 respected?
- Did the consultant pharmacist flag the issue before the injury, and what did the facility do?
- Was medication reconciliation completed after each hospital return?
- Was required monitoring, including labs, ordered and actually drawn?
Which expert fits
- Physician with geriatric prescribing experienceIndication, dosing, monitoring, drug interactions, and causation.
- Consultant pharmacistDrug regimen review standards, unnecessary drug analysis, and pharmacy systems.
- Long-term care RN or Director of NursingAdministration standards, transcription, medication pass practice, and error reporting.
How the other side usually argues it
Written for both sides. Plaintiff counsel should expect these; defense counsel will recognise them. Each answer is a records or regulatory point an expert can support.
The error caused no harm.
Significance under F760 turns on the drug and the potential for harm, not only the outcome. Causation for damages is a separate physician question.
The psychotropic was clinically indicated.
Indication needs a diagnosis, behavior monitoring and gradual dose reduction attempts, now reviewed under F605 rather than the former F758.
The pharmacist never flagged it.
Then the monthly drug regimen reviews under F756 should show that, and the facility's own review duty remains.
Panel members who work these cases
Matched from the ECS panel. Availability and conflicts are confirmed on the call.
Caroline Long
Registered nurse, Wound care certified
Natalie McGonagle
Registered nurse, Assisted living clinical specialist
Deborah Trujillo
Registered nurse, Assisted living clinical specialist
For the paralegal handling this
Request the MAR as a native export if the facility uses an electronic record, not a printed summary. Time stamps and late-entry flags are usually stripped out of the printout, and those are the fields the expert needs.
Related case types
Sepsis and infection
Change in condition, notification timing, delayed transfer, and infection control.
See this case type ›Abuse and neglect
Staff and resident-on-resident abuse, screening, reporting, and investigation.
See this case type ›Understaffing
Staffing sufficiency, PBJ data, assignment sheets, and corporate budget decisions.
See this case type ›Twenty minutes on the care issues
Free screening with a nursing home expert.